Back to School: How biopharma can reboot drug development. Access exclusive analysis here

DIST_0908_j.chembiol.2020.08.013

Small molecule kinase inhibitor for cystic fibrosis with splicing mutation

Sep 29, 2020 | 12:59 AM GMT

DISEASE CATEGORY: Pulmonary

INDICATION: Cystic

Read the full 197 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE